Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, ...
The Global Diabetic Macular Edema Market is experiencing significant growth driven by rising diabetes prevalence and technological advancements in retinal diagnostics like OCT and AI-enabled imaging.
Justine R. Smith receives funding from Macular Disease Foundation Australia, Queensland Eye Institute Foundation, Flinders Foundation and the National Health and Medical Research Council of Australia.
Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...
Your eyesight is precious! So you want to do everything possible to avoid the changes you’re told are a normal part of aging — like trouble seeing at night and cloudy vision. And you can! Research ...
The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the anti-VEGF group. Visual acuity and central macular thickness improved in patients ...
Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In so-called wet AMD, new, abnormal blood vessels grow in the central part of ...
The macula is the center part of your retina. It gives you your central vision, what you see right in front of you. When the macula is damaged, you can still see around the edges of your vision, ...
Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the ...
While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results